
Independent peptide intelligence: clinical evidence, provider and lab scrutiny, regulatory shifts, and the genetics research behind why response varies.
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 94 | Founded | 9 months ago | Last Issue | 7 days ago |
| Active | |||||

At the TPL Genetics booth during PepMed 2026 in Washington, DC.
We brought a booth to PepMed. We came home with a lot more to be excited about.
For two days, The Peptide List and TPL Genetics had the opportunity to meet dozens of doctor...
September 12, 2026
Retatrutide activates GLP-1, GIP and glucagon receptors. BG-104 is reported to combine GLP-1, GIP and growth-hormone receptor agonism with activin type II receptor targeting. Its body-composition findings are from obese...
September 9, 2026
An opportunity is not a receipt.
On page 11 of the FDA’s BPC-157 briefing for its July compounding meeting, two nomination packages describe a substance whose paperwork does not line up. Their identifiers point to BPC-...
On September 4, 2026, Shreeram Aradhye, Novartis’s president of development and chief medical officer, put the disappointment into unusually plain language. The company’s experimental drug had lowered lipoprotein(a), an inherited cardiovasc...
August 28, 2026
Fourteen days can move a signal. Scarred architecture asks a longer question.
Eric W. was in his mid-40s, a practicing primary-care physician, a husband, and a father of two when ordinary movement inside his own clinic st...
Subscribers, engagement, traffic and sponsorship for The Peptide List.
| Subscribers | Engagement | 78 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Where The Peptide List ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 88 | Monthly Search Traffic | Top Keywords |
|---|
The writers behind this newsletter.
Independent peptide research, provider intelligence, lab testing, regulation, and genetics evidence behind person-to-person response. Source-first.
You can find recent issues that have been published by The Peptide List on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The Peptide List, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Peptide List as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Peptide List using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like The Peptide List. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.